Literature DB >> 10508562

An Ava I polymorphism in the TP53 gene.

D Graziani1, S Romagnoli, B Cassani, R M Alfano, M Roncalli, G Coggi.   

Abstract

TP53 gene plays a major role in the process of malignant transformation and tumour progression so that abnormalities such as point mutation or allelic loss of this gene are a common finding in different tumour types. Most of the mutations identified cover a conserved region of the gene, spanning from exon 4 to exon 9. The present report describes a novel polymorphism, 12 nucleotides downstream the splicing junction of exon/intron 9 identified in a cohort of 103 Italian healthy blood donors. The polymorphism results in the creation of a new restriction site for Ava I. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508562     DOI: 10.1006/mcpr.1999.0256

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  4 in total

Review 1.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Analysis of p53 tumor suppressor gene in families with multiple glioma patients.

Authors:  N Paunu; K Syrjäkoski; R Sankila; K O Simola; P Helén; M Niemelä; M Matikainen; J Isola; H Haapasalo
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

3.  Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chandrakumar Shanmugam; Wen Wan; Sreelatha Meleth; Harvey Bumpers; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2009-04-01       Impact factor: 12.531

4.  Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.

Authors:  Venkat R Katkoori; Upender Manne; Lakshmi S Chaturvedi; Marc D Basson; Pam Haan; Daniel Coffey; Harvey L Bumpers
Journal:  Oncotarget       Date:  2017-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.